Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER
No-Receipt date
2020-00564 - 13/02/2020
No-Filing date
20200400423 - 13/02/2020
No-Granting date
3102805 - 06/03/2020
No-EPO application date
14714586.6 - 17/03/2014
No-EPO granting date
2976360 - 27/11/2019
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
3/2020 - 11/05/2020
Expiration date
18/03/2034
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
WOPCT/EP2013/00081718/03/2013/WO
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 39/395
A61P 35/00
C07K 16/28
C07K 16/30
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1124910
ASTELLAS PHARMA INC.
5-1, NIHONBASHI-HONCHO 2-CHOME
CHUO-KU TOKYO 103-8411
JAPAN
1124911
TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG- UNIVERSITAT MAINZ GEMEINNUTZIGE GMBH
FREILIGRATHSTRASSE 12
55131 MAINZ
GERMANY
Inventors
Code
Firstname
Surname
2847538
SAHIN, UGUR
2847539
TURECI, OZLEM
Representatives
Code
Firstname
Surname
Address
Town
Zip
3098
ANNA
GIAKOUMI
ALKAMENOUS 12-14
ATHINA (ATTIKIS)
10439
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
8397
ANDRONIKI
MISIOU
ANALIPSEOS 23 KAI MARATHONOS 27
VRILISSIA (ATTIKIS)
15235
GREECE
Owners History
Title Instruments
Payments history
11 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).